| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| EP Energy (EPE) | TBA | $100.00 | n.a. | |||
| MacroGenics (MGNX) | BofA Merrill Lynch/ Leerink Swann | $60.00 | n.a. | |||
| Stonegate Mortgage (SGM) | BofA Merrill Lynch/ Credit Suisse/ Barclays/ FBR | $100.00 | n.a. | |||
| Surgical Care Affiliates (TBA) | J.P. Morgan/ Citigroup | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Masonite International (DOOR) | Deutsche Bank Securities/ Barclays/ BofA Merrill Lynch | $150.00 | 1-Star | |||
| New Terms | ||||||
| Acceleron Pharma (XLRN) | Citigroup/ Leerink Swann | 4.65 | $13.00 | $15.00 | $65.10 | 2-Stars |
| Benefitfocus (BNFT) | Goldman, Sachs/ Deutsche Bank Securities/ Jefferies | 4.50 | $21.50 | $24.50 | $103.50 | 2-Stars |
| BIND Therapeutics (BIND) | Credit Suisse/ Cowen and Company | 4.70 | $14.00 | $16.00 | $70.50 | 2-Stars |
| Fate Therapeutics (FATE) | Cowen and Company/ BMO Capital Markets | 4.00 | $14.00 | $16.00 | $60.00 | n.a. |
| Five Prime Therapeutics ( FPRX) | Jefferies/ BMO Capital Markets/ Wells Fargo Securities | 4.00 | $12.00 | $14.00 | $52.00 | n.a. |
| OCI Resources LP (OCIR) | Citigroup/ Goldman, Sachs | 5.00 | $19.00 | $21.00 | $100.00 | 2-Stars |
| Tecogen (TGEN) | Northland Securities/ Scarsdale Equities LLC | 3.00 | $5.50 | $7.50 | $19.50 | n.a. |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept.2, 2013 | Manager(s) | Offered | Raised | Price | 9/6/13 | Change |
| None | ||||||
